Asset Dedication, LLC Biogen Inc. Transaction History

Asset Dedication, LLC

$1.25 Billion
Q4 2024

A detailed history of Asset Dedication, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Asset Dedication, LLC holds 104 shares of BIIB stock, worth $15,204. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104

Previous 144 27.78%

Holding current value

$15,204

Previous $27,000 44.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$146.47 - $191.55 $5,858 - $7,662	-40 Reduced 27.78%	104 $15,000
Q3 2024 Oct 15, 2024	SELL	$189.07 - $236.8 $2,457 - $3,078	-13 Reduced 8.28%	144 $27,000
Q2 2024 Aug 06, 2024	SELL	$190.52 - $236.72 $10,097 - $12,546	-53 Reduced 25.24%	157 $36,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $3,292 - $3,716	-13 Reduced 5.83%	210 $54,000
Q4 2022 Jan 19, 2023	SELL	$252.44 - $306.72 $1,767 - $2,147	-7 Reduced 3.04%	223 $63,000
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $2,725 - $3,758	-14 Reduced 5.74%	230 $60,000
Q2 2022 Jul 19, 2022	SELL	$187.54 - $223.02 $3,750 - $4,460	-20 Reduced 7.58%	244 $50,000
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $1,356 - $1,708	-7 Reduced 2.58%	264 $55,000
Q4 2021 Jan 21, 2022	SELL	$223.92 - $287.77 $17,017 - $21,870	-76 Reduced 21.9%	271 $65,000
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $1,457 - $1,707	-6 Reduced 1.7%	347 $99,000
Q4 2020 Jan 28, 2021	SELL	$236.26 - $355.63 $87,179 - $131,227	-369 Reduced 51.11%	353 $84,000
Q3 2020 Oct 20, 2020	BUY	$264.77 - $305.71 $5,030 - $5,808	19 Added 2.7%	722 $208,000
Q2 2020 Aug 24, 2020	SELL	$258.66 - $342.55 $156,489 - $207,242	-605 Reduced 46.25%	703 $186,000
Q1 2020 May 05, 2020	BUY	$268.85 - $341.04 $244,653 - $310,346	910 Added 228.64%	1,308 $413,000
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $1,320 - $1,824	6 Added 1.53%	398 $119,000
Q3 2019 Oct 17, 2019	SELL	$217.44 - $243.88 $4,566 - $5,121	-21 Reduced 5.08%	392 $92,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $3,899 - $4,938	-14 Reduced 3.28%	413 $124,000
Q4 2017 Jan 17, 2018	SELL	$307.64 - $344.58 $9,229 - $10,337	-30 Reduced 6.56%	427 $133,000
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $128,485 - $150,668	457	457 $142,000

Others Institutions Holding BIIB

# of Institutions

1,006

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.

Account

Asset Dedication, LLC Biogen Inc. Transaction History